T1 glottic laryngeal cancer : the role of routine follow-up visits in detecting local recurrence
Pakkanen, Pihla; Ilmarinen, Taru; Halme, Elina; Irjala, Heikki; Koivunen, Petri; Pukkila, Matti; Ventelä, Sami; Hagström, Jaana; Aaltonen, Leena Maija (2021-08-06)
Pakkanen, Pihla
Ilmarinen, Taru
Halme, Elina
Irjala, Heikki
Koivunen, Petri
Pukkila, Matti
Ventelä, Sami
Hagström, Jaana
Aaltonen, Leena Maija
06.08.2021
European Archives of Oto-Rhino-Laryngology
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202109087010
https://urn.fi/URN:NBN:fi:tuni-202109087010
Kuvaus
Peer reviewed
Tiivistelmä
Purpose: We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC). Methods: Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected. Results: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year disease-specific survival (DSS) or laryngeal preservation rate. Conclusion: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems beneficial. Trial registration: Trial registration number and date of registration HUS/356/2017 11.12.2017.
Kokoelmat
- TUNICRIS-julkaisut [17105]